{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:22:24Z","timestamp":1761675744670},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2393-10-11","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T19:14:44Z","timestamp":1268248484000},"source":"Crossref","is-referenced-by-count":8,"title":["APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women"],"prefix":"10.1186","volume":"10","author":[{"given":"Sara","family":"Sedano-Balb\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majella","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"275_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"RM Bertina","year":"1994","unstructured":"Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Velden van der PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994, 369: 64-67. 10.1038\/369064a0.","journal-title":"Nature"},{"issue":"Suppl 1","key":"275_CR2","first-page":"3","volume":"49","author":"B Dahlback","year":"1997","unstructured":"Dahlback B: Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis. Rev Invest Clin. 1997, 49 (Suppl 1): 3-5.","journal-title":"Rev Invest Clin"},{"key":"275_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0037-1616237","volume":"86","author":"I Martinelli","year":"2001","unstructured":"Martinelli I: Risk factors in venous thromboembolism. Thromb Haemost. 2001, 86: 395-403.","journal-title":"Thromb Haemost"},{"key":"275_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM199901073400102","volume":"340","author":"MJ Kupferminc","year":"1999","unstructured":"Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB: Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999, 340: 9-13. 10.1056\/NEJM199901073400102.","journal-title":"N Engl J Med"},{"key":"275_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2298\/VSP0503201D","volume":"62","author":"V Dordevic","year":"2005","unstructured":"Dordevic V, Rakicevic L, Spasic M, Mikovic D, Kovac M, Radojkovic D: [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium]. Vojnosanit Pregl. 2005, 62: 201-205.","journal-title":"Vojnosanit Pregl"},{"key":"275_CR6","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1073\/pnas.90.3.1004","volume":"90","author":"B Dahlback","year":"1993","unstructured":"Dahlback B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993, 90: 1004-1008. 10.1073\/pnas.90.3.1004.","journal-title":"Proc Natl Acad Sci USA"},{"key":"275_CR7","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0140-6736(94)92939-4","volume":"343","author":"J Voorberg","year":"1994","unstructured":"Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Cate JW, Mertens K, van Mourik JA: Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet. 1994, 343: 1535-1536. 10.1016\/S0140-6736(94)92939-4.","journal-title":"Lancet"},{"key":"275_CR8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V91.4.1140","volume":"91","author":"D Williamson","year":"1998","unstructured":"Williamson D, Brown K, Luddington R, Baglin C, Baglin T: Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C. Blood. 1998, 91: 1140-1144.","journal-title":"Blood"},{"key":"275_CR9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V91.4.1135","volume":"91","author":"WP Chan","year":"1998","unstructured":"Chan WP, Lee CK, Kwong YL, Lam CK, Liang R: A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood. 1998, 91: 1135-1139.","journal-title":"Blood"},{"key":"275_CR10","first-page":"139","volume":"24","author":"B Dahlback","year":"1994","unstructured":"Dahlback B: Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis. 1994, 24: 139-151.","journal-title":"Haemostasis"},{"key":"275_CR11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-0038-1650219","volume":"75","author":"B Lunghi","year":"1996","unstructured":"Lunghi B, Iacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F: Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost. 1996, 75: 45-48.","journal-title":"Thromb Haemost"},{"key":"275_CR12","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V90.4.1552","volume":"90","author":"F Bernardi","year":"1997","unstructured":"Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, Mannucci PM: A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood. 1997, 90: 1552-1557.","journal-title":"Blood"},{"key":"275_CR13","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1073\/pnas.84.14.4846","volume":"84","author":"RJ Jenny","year":"1987","unstructured":"Jenny RJ, Pittman DD, Toole JJ, Kriz RW, Aldape RA, Hewick RM, Kaufman RJ, Mann KG: Complete cDNA and derived amino acid sequence of human factor V. Proc Natl Acad Sci USA. 1987, 84: 4846-4850. 10.1073\/pnas.84.14.4846.","journal-title":"Proc Natl Acad Sci USA"},{"key":"275_CR14","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1172\/JCI117623","volume":"94","author":"B Zoller","year":"1994","unstructured":"Zoller B, Svensson PJ, He X, Dahlback B: Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 1994, 94: 2521-2524. 10.1172\/JCI117623.","journal-title":"J Clin Invest"},{"key":"275_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0037-1612907","volume":"85","author":"L Hoekema","year":"2001","unstructured":"Hoekema L, Castoldi E, Tans G, Girelli D, Gemmati D, Bernardi F, Rosing J: Functional properties of factor V and factor Va encoded by the R2-gene. Thromb Haemost. 2001, 85: 75-81.","journal-title":"Thromb Haemost"},{"key":"275_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0049-3848(96)00177-6","volume":"84","author":"AF Schlit","year":"1996","unstructured":"Schlit AF, Col-De Beys C, Moriau M, Lavenne-Pardonge E: Acquired activated protein C resistance in pregnancy. Thromb Res. 1996, 84: 203-206. 10.1016\/0049-3848(96)00177-6.","journal-title":"Thromb Res"},{"issue":"12","key":"275_CR17","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/humrep\/deh532","volume":"19","author":"MH Osama","year":"2004","unstructured":"Osama MH, Justin C: The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome. Human Reproduction. 2004, 19 (12): 2952-2958. 10.1093\/humrep\/deh532.","journal-title":"Human Reproduction"},{"key":"275_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2174\/1389450054545971","volume":"6","author":"M Sugiura","year":"2005","unstructured":"Sugiura M: Pregnancy and delivery in protein C-deficiency. Curr Drug Targets. 2005, 6: 577-583. 10.2174\/1389450054545971.","journal-title":"Curr Drug Targets"},{"key":"275_CR19","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1034\/j.1600-0412.2002.811106.x","volume":"81","author":"C Benedetto","year":"2002","unstructured":"Benedetto C, Marozio L, Tavella AM, Maula V, Carmignani D, Curti A: Response to activated protein C decreases throughout pregnancy. Acta Obstet Gynecol Scand. 2002, 81: 1028-1032.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"275_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/MBC.0b013e3282f09835","volume":"18","author":"B Mahieu","year":"2007","unstructured":"Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, Weyler J, Jacquemyn Y, Planken Van der M: Haemostiatic changes and acquired activated protein C resistance in normal pregnancy. Blood Coagulation and Fibrinolysis. 2007, 18: 685-688. 10.1097\/MBC.0b013e3282f09835.","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"275_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/MBC.0b013e3282f09835","volume":"18","author":"B Mahieu","year":"2007","unstructured":"Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, Weyler J, Jacquemyn Y, Planken Van der M: Haemostiatic changes and acquired activated protein C resistance in normal pregnancy. Blood Coagulation and Fibrinolysis. 2007, 18: 685-688. 10.1097\/MBC.0b013e3282f09835.","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"275_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1034\/j.1399-0004.2003.00017.x","volume":"63","author":"J Devaney","year":"2003","unstructured":"Devaney J, Glennon M, Farrell G, Ruttledge M, Smith T, Houghton JA, Maher M: Cystic fibrosis mutation frequencies in an Irish population. Clin Genet. 2003, 63: 121-125. 10.1034\/j.1399-0004.2003.00017.x.","journal-title":"Clin Genet"},{"key":"275_CR23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0002-9378(97)70456-3","volume":"177","author":"MC Walker","year":"1997","unstructured":"Walker MC, Garner PR, Keely EJ, Rock GA, Reis MD: Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol. 1997, 177: 162-169. 10.1016\/S0002-9378(97)70456-3.","journal-title":"Am J Obstet Gynecol"},{"key":"275_CR24","volume-title":"Chromogenix AB; Product Monograph 1997 Version 2.1","author":"F Axelsson","year":"1997","unstructured":"Axelsson F, Rosen S: APC resistance. Chromogenix AB; Product Monograph 1997 Version 2.1. 1997"},{"key":"275_CR25","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1056\/NEJM199504063321403","volume":"332","author":"PM Ridker","year":"1995","unstructured":"Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995, 332: 912-917. 10.1056\/NEJM199504063321403.","journal-title":"N Engl J Med"},{"key":"275_CR26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1182\/blood.V91.1.364","volume":"91","author":"B Lunghi","year":"1998","unstructured":"Lunghi B, Castoldi E, Mingozzi F, Bernardi F: A new factor V gene polymorphism (His 1254 Arg) present in subjects of african origin mimics the R2 polymorphism (His 1299 Arg). Blood. 1998, 91: 364-365.","journal-title":"Blood"},{"key":"275_CR27","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698","volume":"88","author":"SR Poort","year":"1996","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996, 88: 3698-3703.","journal-title":"Blood"},{"key":"275_CR28","first-page":"509","volume":"8","author":"F Peng","year":"2001","unstructured":"Peng F, Labelle LA, Rainey BJ, Tsongalis GJ: Single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene are common in US Caucasian and Hispanic American populations. Int J Mol Med. 2001, 8: 509-511.","journal-title":"Int J Mol Med"},{"key":"275_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.siny.2004.03.007","volume":"9","author":"C Bamberg","year":"2004","unstructured":"Bamberg C, Kalache KD: Prenatal diagnosis of fetal growth restriction. Semin Fetal Neonatal Med. 2004, 9: 387-394. 10.1016\/j.siny.2004.03.007.","journal-title":"Semin Fetal Neonatal Med"},{"key":"275_CR30","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1073\/pnas.91.4.1396","volume":"91","author":"B Dahlback","year":"1994","unstructured":"Dahlback B, Hildebrand B: Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA. 1994, 91: 1396-1400. 10.1073\/pnas.91.4.1396.","journal-title":"Proc Natl Acad Sci USA"},{"key":"275_CR31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0038-1653795","volume":"74","author":"JH Griffin","year":"1995","unstructured":"Griffin JH, Heeb MJ, Kojima Y, Fernandez JA, Kojima K, Hackeng TM, Greengard JS: Activated protein C resistance: molecular mechanisms. Thromb Haemost. 1995, 74: 444-448.","journal-title":"Thromb Haemost"},{"key":"275_CR32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1055\/s-0038-1642720","volume":"74","author":"RM Bertina","year":"1995","unstructured":"Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP: Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost. 1995, 74: 449-453.","journal-title":"Thromb Haemost"},{"key":"275_CR33","first-page":"317","volume-title":"Thromb Haemost Suppl","author":"G Siegert","year":"1997","unstructured":"Siegert G, Gehrish S, Schellong S, Schwarz T, Runge E, L\u00fcthke K: Decreased APC-response in patients lacking factor V-Leiden-Laboratory diagnostic and clinical relevance. Thromb Haemost Suppl. 1997, 317-318."},{"key":"275_CR34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0037-1612659","volume":"85","author":"P Clark","year":"2001","unstructured":"Clark P, Sattar N, Walker I, Greer I: The Glasgow outcome, APCR and lipid (GOAL) pregnancy study: significance of pregnancy - associated activated protein C resistance. Thromb Haemostasis. 2001, 85: 30-35.","journal-title":"Thromb Haemostasis"},{"key":"275_CR35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1055\/s-0037-1614518","volume":"81","author":"H Kjellberg","year":"1999","unstructured":"Kjellberg H, Andersson M, Rosen S, Tengorn L, Hellgren M: APC Resistance and other Haemostatic variables during pregnancy and Puerperium. Thromb Haemost. 1999, 81: 527-531.","journal-title":"Thromb Haemost"},{"key":"275_CR36","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH03-09-0554","volume":"91","author":"A Dossenbach-Glaninger","year":"2004","unstructured":"Dossenbach-Glaninger A, Von Trotsemburger M, Krugluger W, Dossenbach M, Oberkanins C, Huber J, Hopmeier P: Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss. Thromb Haemost. 2004, 91: 694-699.","journal-title":"Thromb Haemost"},{"issue":"4","key":"275_CR37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1055\/s-0037-1614545","volume":"81","author":"J Vaughan","year":"1999","unstructured":"Vaughan J, Power C, Nolan C, McCarthy D, Shirley I: The incidence of factor V Leiden in a normal Irish population and its relationship to the laboratory diagnosis of APC resistance. Letter;Thromb Haemost. 1999, 81 (4): 661-3.","journal-title":"Letter;Thromb Haemost"},{"key":"275_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1046\/j.1365-2141.2000.02371.x","volume":"111","author":"WJ Livingstone","year":"2000","unstructured":"Livingstone WJ, Keenan C, White B, Mynett-Johnson L, Lawler M, Mayne P, Smith OP: Prevalence of the factor VR506Q mutation in two Irish control populations: use of a novel nested polymerase chain reaction approach. Br J Haematol. 2000, 111: 559-561. 10.1046\/j.1365-2141.2000.02371.x.","journal-title":"Br J Haematol"},{"key":"275_CR39","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2174\/092986708784638852","volume":"15","author":"GL Pelle","year":"2008","unstructured":"Pelle GL, Bj\u00f6rn D: Carriership of Factor V Leiden and Evolutionary Selection Advantage. Current Medicinal Chemistry. 2008, 15: 1541-1544. 10.2174\/092986708784638852.","journal-title":"Current Medicinal Chemistry"},{"key":"275_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/09674845.2004.11732662","volume":"61","author":"D Harvey","year":"2004","unstructured":"Harvey D, Lowe GM: Factor V Leiden: association with venous thromboembolism in pregnancy and screening issues. Br J Biomed Sci. 2004, 61: 157-164.","journal-title":"Br J Biomed Sci"},{"key":"275_CR41","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0038-1665404","volume":"75","author":"LC Chan","year":"1996","unstructured":"Chan LC, Bourke C, Lam CK, Liu HW, Brookes S, Jenkins V, Pasi J: Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors--correlation with absence of Arg506-Gln mutation of factor V gene. Thromb Haemost. 1996, 75: 522-523.","journal-title":"Thromb Haemost"},{"key":"275_CR42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0037-1614024","volume":"84","author":"G Castaman","year":"2000","unstructured":"Castaman G, Ruggeri M, Tosetto A, Rodeghiero F: Heterogeneity of activated protein C resistance phenotype in subjects with compound heterozygosity for HR2 haplotype and FV Leiden mutation (R506Q) in factor V gene. Thromb Haemost. 2000, 84: 357-358.","journal-title":"Thromb Haemost"},{"key":"275_CR43","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1055\/s-0037-1616628","volume":"93","author":"A Santamaria","year":"2005","unstructured":"Santamaria A, Soria JM, Tirado I, Mateo J, Coll I, Souto JC, Fontcuberta J: Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family. Thromb Haemost. 2005, 93: 1193-1195.","journal-title":"Thromb Haemost"},{"key":"275_CR44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V86.1.219.bloodjournal861219","volume":"86","author":"S Gandrille","year":"1995","unstructured":"Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M: Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM. Blood. 1995, 86: 219-224.","journal-title":"Blood"},{"key":"275_CR45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0037-1613866","volume":"83","author":"MC De Visser","year":"2000","unstructured":"De Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM: The HR2 haplotype of factor V: effects on factor V levels, normalised activated protein C sensitivity ratios and the risk of venous thrombosis. Thromb Haemost. 2000, 83: 577-582.","journal-title":"Thromb Haemost"},{"key":"275_CR46","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1055\/s-0037-1615057","volume":"79","author":"P Clark","year":"1998","unstructured":"Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID: Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost. 1998, 79: 1166-1170.","journal-title":"Thromb Haemost"},{"key":"275_CR47","first-page":"2085","volume":"3","author":"TA Bayston","year":"1994","unstructured":"Bayston TA, Ireland H, Olds RJ, Thein SL, Lane DA: A polymorphism in the human coagulation factor V gene. Hum Mol Genet. 1994, 3: 2085-","journal-title":"Hum Mol Genet"},{"key":"275_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0049-3848(00)00283-8","volume":"99","author":"H Kostka","year":"2000","unstructured":"Kostka H, Siegert G, Schwarz T, Gehrisch S, Kuhlisch E, Schellong S, Jaross W: Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients. Thromb Res. 2000, 99: 539-547. 10.1016\/S0049-3848(00)00283-8.","journal-title":"Thromb Res"},{"key":"275_CR49","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1182\/blood.V98.2.358","volume":"98","author":"R van Wijk","year":"2001","unstructured":"van Wijk R, Nieuwenhuis K, Berg van den M, Huizinga EG, Meijden van der BB, Kraaijenhagen RJ, van Solinge WW: Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood. 2001, 98: 358-367. 10.1182\/blood.V98.2.358.","journal-title":"Blood"},{"key":"275_CR50","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0021-9258(17)37898-5","volume":"254","author":"CT Esmon","year":"1979","unstructured":"Esmon CT: The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity. J Biol Chem. 1979, 254: 964-973.","journal-title":"J Biol Chem"},{"key":"275_CR51","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1021\/bi00481a003","volume":"29","author":"WH Kane","year":"1990","unstructured":"Kane WH, Devore-Carter D, Ortel TL: Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting region. Biochemistry. 1990, 29: 6762-6768. 10.1021\/bi00481a003.","journal-title":"Biochemistry"},{"key":"275_CR52","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.1073\/pnas.83.16.5939","volume":"83","author":"JJ Toole","year":"1986","unstructured":"Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ: A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc Natl Acad Sci USA. 1986, 83: 5939-5942. 10.1073\/pnas.83.16.5939.","journal-title":"Proc Natl Acad Sci USA"},{"key":"275_CR53","doi-asserted-by":"publisher","first-page":"16140","DOI":"10.1074\/jbc.273.26.16140","volume":"273","author":"E Thorelli","year":"1998","unstructured":"Thorelli E, Kaufman RJ, Dahlback B: The C-terminal Region of the Factor V B-domain Is Crucial for the Anticoagulant Activity of Factor V. J Biol Chem. 1998, 273: 16140-16145. 10.1074\/jbc.273.26.16140.","journal-title":"J Biol Chem"},{"key":"275_CR54","doi-asserted-by":"crossref","first-page":"18735","DOI":"10.1016\/S0021-9258(17)32228-7","volume":"269","author":"L Shen","year":"1994","unstructured":"Shen L, Dahlback B: Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa. J Biol Chem. 1994, 269: 18735-18738.","journal-title":"J Biol Chem"},{"key":"275_CR55","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood.V87.11.4708.bloodjournal87114708","volume":"87","author":"D Lu","year":"1996","unstructured":"Lu D, Kalafatis M, Mann KG, Long GL: Comparison of activated protein C\/protein S-mediated inactivation of human factor VIII and factor V. Blood. 1996, 87: 4708-4717.","journal-title":"Blood"},{"key":"275_CR56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0038-1650556","volume":"76","author":"K Varadi","year":"1996","unstructured":"Varadi K, Rosing J, Tans G, Pabinger I, Keil B, Schwarz HP: Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemost. 1996, 76: 208-214.","journal-title":"Thromb Haemost"},{"key":"275_CR57","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1021\/bi0361362","volume":"43","author":"KW Sorensen","year":"2004","unstructured":"Sorensen KW, Nicolaes GA, Villoutreix BO, Yamazaki T, Tans G, Rosing J, Dahlback B: Functional properties of recombinant factor V mutated in a potential calcium-binding site. Biochemistry. 2004, 43: 5803-5810. 10.1021\/bi0361362.","journal-title":"Biochemistry"},{"key":"275_CR58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1021\/bi00168a013","volume":"33","author":"M Kalafatis","year":"1994","unstructured":"Kalafatis M, Rand MD, Mann KG: Factor Va-membrane interaction is mediated by two regions located on the light chain of the cofactor. Biochemistry. 1994, 33: 486-493. 10.1021\/bi00168a013.","journal-title":"Biochemistry"},{"key":"275_CR59","doi-asserted-by":"publisher","first-page":"6538","DOI":"10.1021\/bi00187a022","volume":"33","author":"M Kalafatis","year":"1994","unstructured":"Kalafatis M, Xue J, Lawler CM, Mann KG: Contribution of the heavy and light chains of factor Va to the interaction with factor Xa. Biochemistry. 1994, 33: 6538-6545. 10.1021\/bi00187a022.","journal-title":"Biochemistry"},{"key":"275_CR60","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1093\/humrep\/dem210","volume":"22","author":"F Dawood","year":"2007","unstructured":"Dawood F, Mountford R, Farquharson R, Quenby S: Genetic polymorphisms on the factor V gene in women with recurrent miscarriage and acquired APCR. Hum Reprod. 2007, 22: 2546-2553. 10.1093\/humrep\/dem210.","journal-title":"Hum Reprod"},{"key":"275_CR61","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/01.AOG.0000173986.32528.ca","volume":"106","author":"DS Dizon-Townson","year":"2005","unstructured":"Dizon-Townson DS, Miller DM, Sibai B, Spong CY, Thom E, Wendel GJ, Wensreom K, Samuels P, Xotroneo MA, Moawad A, Sorodin Y, Meis P, Miodovnik M, O'Sulivan MJ, Conway D, Wapner RJ, Gabbe SG: The relationshep of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005, 106: 517-524.","journal-title":"Obstet Gynecol"},{"key":"275_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","volume":"132","author":"L Robertson","year":"2006","unstructured":"Robertson L, Wu O, Langhorne L, Twaddle S, Clak P, Lowe GD, Walker ID, Greaves M, Brenkel L, Regan L, Greer IA: Thrombophilia in pregnancy: a systematic review. Br J Hematol. 2006, 132: 171-196. 10.1111\/j.1365-2141.2005.05847.x.","journal-title":"Br J Hematol"},{"key":"275_CR63","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1093\/humrep\/14.12.3112","volume":"14","author":"BS Horstkamp","year":"1999","unstructured":"Horstkamp BS, Kiess H, Kr\u00e4mer J, Riess H, W H, Dudenhausen JW: Activated protein C resistance shows an association with pregnancy-induced hypertension. Hum Reprod. 1999, 14: 3112-3115. 10.1093\/humrep\/14.12.3112.","journal-title":"Hum Reprod"},{"key":"275_CR64","first-page":"1161","volume":"27","author":"S Demir","year":"2006","unstructured":"Demir S, Evruke C, Ozgunen T, Kadayifci O, Altintas U, Kokangul S: The relationship between pregnancy induced hypertension and congenital thrombophilia. SMJ. 2006, 27: 1161-1166.","journal-title":"SMJ"},{"key":"275_CR65","first-page":"144","volume":"117","author":"A Tranquilli","year":"2004","unstructured":"Tranquilli A, Giannubilo S, Dell'Uomo B, Grandone E: Adverse pregnancy outcomes are associated with multiple maternal thrombophilic factors. EJOG. 2004, 117: 144-147.","journal-title":"EJOG"},{"key":"275_CR66","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1586\/17474108.2.2.203","volume":"2","author":"A Weintraub","year":"2007","unstructured":"Weintraub A, Fernanda Press F, Arnon Wiznitzer A, Sheiner E: Maternal thrombophilia and adverse pregnancy outcomes. Expet Rev Obstet Gyneco. 2007, 2: 203-216. 10.1586\/17474108.2.2.203.","journal-title":"Expet Rev Obstet Gyneco"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2393-10-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-10-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-10-11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2393-10-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T18:08:29Z","timestamp":1635098909000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/1471-2393-10-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1186\/1471-2393-10-11","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]},"article-number":"11"}}